QUOTED. Jeff Shuren.
US FDA device center director Jeff Shuren said on 22 July that the agency is worried about the Delta variant, but is taking steps necessary to ensure that coronavirus diagnostics give accurate readings. See what Shuren had to say about developing COVID-19 diagnostics here.
“Developers should “design tests in the first place to make them … more resistant to adverse impacts.” – Jeff Shuren, director, US FDA’s device center
Click here for a free trial of Medtech Insight